Literature DB >> 12728277

Progress and problems with the use of viral vectors for gene therapy.

Clare E Thomas1, Anja Ehrhardt, Mark A Kay.   

Abstract

Gene therapy has a history of controversy. Encouraging results are starting to emerge from the clinic, but questions are still being asked about the safety of this new molecular medicine. With the development of a leukaemia-like syndrome in two of the small number of patients that have been cured of a disease by gene therapy, it is timely to contemplate how far this technology has come, and how far it still has to go.

Entities:  

Mesh:

Year:  2003        PMID: 12728277     DOI: 10.1038/nrg1066

Source DB:  PubMed          Journal:  Nat Rev Genet        ISSN: 1471-0056            Impact factor:   53.242


  645 in total

Review 1.  Nanoparticles for retinal gene therapy.

Authors:  Shannon M Conley; Muna I Naash
Journal:  Prog Retin Eye Res       Date:  2010-05-07       Impact factor: 21.198

2.  Extended and stable gene expression via nucleofection of MIDGE construct into adult human marrow mesenchymal stromal cells.

Authors:  P L Mok; S K Cheong; C F Leong; K H Chua; O Ainoon
Journal:  Cytotechnology       Date:  2011-12-10       Impact factor: 2.058

Review 3.  Liver-directed gene therapy for dyslipidemia and diabetes.

Authors:  Kazuhiro Oka; Lawrence Chan
Journal:  Curr Atheroscler Rep       Date:  2004-05       Impact factor: 5.113

Review 4.  Recent developments and current status of gene therapy using viral vectors in the United Kingdom.

Authors:  Kate Relph; Kevin Harrington; Hardev Pandha
Journal:  BMJ       Date:  2004-10-09

Review 5.  Gene therapy in clinical medicine.

Authors:  S M Selkirk
Journal:  Postgrad Med J       Date:  2004-10       Impact factor: 2.401

Review 6.  A realistic chance for gene therapy in the near future.

Authors:  Stefan Worgall
Journal:  Pediatr Nephrol       Date:  2004-11-10       Impact factor: 3.714

Review 7.  Gene Delivery in Neuro-Oncology.

Authors:  Karan Dixit; Priya Kumthekar
Journal:  Curr Oncol Rep       Date:  2017-09-02       Impact factor: 5.075

Review 8.  Physical non-viral gene delivery methods for tissue engineering.

Authors:  Adam J Mellott; M Laird Forrest; Michael S Detamore
Journal:  Ann Biomed Eng       Date:  2012-10-26       Impact factor: 3.934

9.  Gene delivery in malignant B cells using the combination of lentiviruses conjugated to anti-transferrin receptor antibodies and an immunoglobulin promoter.

Authors:  Lai Sum Leoh; Kouki Morizono; Kathleen M Kershaw; Irvin S Y Chen; Manuel L Penichet; Tracy R Daniels-Wells
Journal:  J Gene Med       Date:  2014 Jan-Feb       Impact factor: 4.565

10.  The effect of side-chain functionality and hydrophobicity on the gene delivery capabilities of cationic helical polypeptides.

Authors:  Rujing Zhang; Nan Zheng; Ziyuan Song; Lichen Yin; Jianjun Cheng
Journal:  Biomaterials       Date:  2014-01-15       Impact factor: 12.479

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.